Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2025-12-28 @ 12:10 AM
Study NCT ID:
NCT01239394
Status:
COMPLETED
Last Update Posted:
2017-10-18
First Post:
2010-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-10
First Submit QC Date:
None
Study First Post Date:
2010-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-25
Results First Submit QC Date:
None
Results First Post Date:
2017-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-18
Last Update Post Date:
2017-10-18
Last Update Post Date Type:
ACTUAL